| Characteristics | Number (n = 22) | Percentage (%) | 
| Age | 
 | 
 | 
| median 51.5 (range 20 - 65) | 
 | 
 | 
| ≤45 | 8 | 36.4% | 
| >45 | 14 | 63.6% | 
| Sex | 
 | 
 | 
| Male | 16 | 72.7% | 
| Female | 6 | 27.3% | 
| ECOG performance status | 
 | 
 | 
| 1 | 15 | 68.2% | 
| 2 | 7 | 31.8% | 
| Site of primary tumors | 
 | 
 | 
| frontal | 7 | 31.8% | 
| temporal | 14 | 63.6% | 
| parietal | 15 | 68.2% | 
| occipital | 2 | 9.1% | 
| ventricular | 1 | 4.5% | 
| Primary surgery | 
 | 
 | 
| Biopsy | 3 | 13.6% | 
| Subtotal excision | 17 | 77.3% | 
| Maximal safe resection | 2 | 9.1% | 
| Primary systemic treatment | 
 | 
 | 
| Temozolamide | 14 | 63.6% | 
| PCV protocol | 8 | 36.4% |